M

MAP Pharmaceuticals

119 employees

MAP Pharmaceuticals is focused on developing novel inhalation therapies for respiratory and systemic diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
inhalation technology and neurology and device delivery systems
Medical
Pharmaceutical

Date founded

2005

Funding rounds raised

Total raised

$50M

from 10 investors over 10 rounds

M

MAP Pharmaceuticals raised $50M on March 28, 2007

Investors: Sky Ventures, The D. E. Shaw Group, Perseus, Brookside Capital Inc and Bay City Capital

M

MAP Pharmaceuticals raised $25M on January 31, 2006

Investors: Sky Ventures, Bay City Capital and Perseus

M

MAP Pharmaceuticals raised $30M on September 7, 2004

Investors: Sky Ventures and Bay City Capital

FAQ